Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
PURE BIOSCIENCE, INC. (PURE)
Standardized SEC financial data for PURE BIOSCIENCE, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001006028 · OTC · Miscellaneous Chemical Products.
Gross margin
59.2%
Operating margin
-103.2%
Net margin
-109.0%
Revenue growth (YoY)
12.6%
Return on equity
46.9%
Free cash flow
-$2.0M
Debt / equity
0.00×
Current ratio
1.12×
Ratios for fiscal year 2025, standardized from SEC filings.